ABL1 and breast carcinoma: Notably, a recent report also mentioned that loss of function of ABL1 and/or ABL2 does not inhibit breast cancer metastasis to the lung (Wang et al., 2016), which further demonstrated that ABL does not play crucial roles in the anti-metastatic function of Ponatinib.